FUJIFILM Sonosite has introduced its latest portable ultrasound device, the Sonosite MT, expanding its existing range of point-of-care imaging systems that include the Sonosite PX, LX, and ST models.
The Sonosite MT is designed in a clamshell style, allowing for flexible use both with and without its stand. Its compact and lightweight build allows staff to move it quickly between locations as needed.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It claims to deliver clear images that support diagnoses across a broad range of patient groups.
The absence of buttons on the monitor and control panel facilitates easier cleaning and disinfecting, which is an important feature for managing infection risks in healthcare facilities.
Additionally, the device is integrated with Synapse Synchronicity workflow manager for daily operations.
The device’s fully touchscreen interface is harmonised with the broader FUJIFILM Sonosite portfolio.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe launch of Sonosite MT, according to the company, underscores FUJIFILM Sonosite’s ongoing focus on point-of-care ultrasound by supplying healthcare practitioners with imaging tools.
FUJIFILM Sonosite distributes its products globally in more than 100 nations.
FUJIFILM Sonosite president and CEO Richard Fabian said: “At FUJIFILM Sonosite, our mission is to empower clinicians with ultrasound systems that perform reliably in the most demanding clinical settings. Sonosite MT exemplifies this mission by integrating our core product pillars: durability, reliability, and ease of use.
“This new system continues our journey of excellence, providing a portable ultrasound platform that supports both clinical confidence and operational efficiency.”
In March 2025, FUJIFILM Healthcare Americas disclosed a partnership with Singapore-based Us2.ai to incorporate AI-driven image analysis into its LISENDO 880 and LISENDO 800 cardiovascular ultrasound platforms, aiming to enhance heart disease diagnostic workflows.